Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Azithromycin Tablets is an antibiotic that fights bacteria. It is used to treat many different types of infections caused by bacteria, such as respiratory infections, skin infections, ear infections, eye infections, and sexually transmitted diseases.
Global Azithromycin Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Azithromycin Tablets market research.
Key manufacturers engaged in the Azithromycin Tablets industry include Teva, CSPC, Novartis, wockhardt, Aurobindo Pharma, Sun Pharmaceutical Industries, Lupin Pharmaceuticals, Lannett Company and Apotex, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Azithromycin Tablets were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Azithromycin Tablets market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Azithromycin Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Azithromycin Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Azithromycin Tablets Market Overview
1.1 Product Overview and Scope of Azithromycin Tablets
1.2 Azithromycin Tablets Segment by Type
1.2.1 Global Azithromycin Tablets Market Value Comparison by Type (2023-2029)
1.2.2 250mg
1.2.3 500mg
1.3 Azithromycin Tablets Segment by Application
1.3.1 Global Azithromycin Tablets Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Azithromycin Tablets Market Size Estimates and Forecasts
1.4.1 Global Azithromycin Tablets Revenue 2018-2029
1.4.2 Global Azithromycin Tablets Sales 2018-2029
1.4.3 Global Azithromycin Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Azithromycin Tablets Market Competition by Manufacturers
2.1 Global Azithromycin Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Azithromycin Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Azithromycin Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Azithromycin Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Azithromycin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azithromycin Tablets, Product Type & Application
2.7 Azithromycin Tablets Market Competitive Situation and Trends
2.7.1 Azithromycin Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Azithromycin Tablets Players Market Share by Revenue
2.7.3 Global Azithromycin Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Azithromycin Tablets Retrospective Market Scenario by Region
3.1 Global Azithromycin Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Azithromycin Tablets Global Azithromycin Tablets Sales by Region: 2018-2029
3.2.1 Global Azithromycin Tablets Sales by Region: 2018-2023
3.2.2 Global Azithromycin Tablets Sales by Region: 2024-2029
3.3 Global Azithromycin Tablets Global Azithromycin Tablets Revenue by Region: 2018-2029
3.3.1 Global Azithromycin Tablets Revenue by Region: 2018-2023
3.3.2 Global Azithromycin Tablets Revenue by Region: 2024-2029
3.4 North America Azithromycin Tablets Market Facts & Figures by Country
3.4.1 North America Azithromycin Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Azithromycin Tablets Sales by Country (2018-2029)
3.4.3 North America Azithromycin Tablets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Azithromycin Tablets Market Facts & Figures by Country
3.5.1 Europe Azithromycin Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Azithromycin Tablets Sales by Country (2018-2029)
3.5.3 Europe Azithromycin Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azithromycin Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Azithromycin Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Azithromycin Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Azithromycin Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Azithromycin Tablets Market Facts & Figures by Country
3.7.1 Latin America Azithromycin Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Azithromycin Tablets Sales by Country (2018-2029)
3.7.3 Latin America Azithromycin Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azithromycin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Azithromycin Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Azithromycin Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Azithromycin Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Azithromycin Tablets Sales by Type (2018-2029)
4.1.1 Global Azithromycin Tablets Sales by Type (2018-2023)
4.1.2 Global Azithromycin Tablets Sales by Type (2024-2029)
4.1.3 Global Azithromycin Tablets Sales Market Share by Type (2018-2029)
4.2 Global Azithromycin Tablets Revenue by Type (2018-2029)
4.2.1 Global Azithromycin Tablets Revenue by Type (2018-2023)
4.2.2 Global Azithromycin Tablets Revenue by Type (2024-2029)
4.2.3 Global Azithromycin Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Azithromycin Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Azithromycin Tablets Sales by Application (2018-2029)
5.1.1 Global Azithromycin Tablets Sales by Application (2018-2023)
5.1.2 Global Azithromycin Tablets Sales by Application (2024-2029)
5.1.3 Global Azithromycin Tablets Sales Market Share by Application (2018-2029)
5.2 Global Azithromycin Tablets Revenue by Application (2018-2029)
5.2.1 Global Azithromycin Tablets Revenue by Application (2018-2023)
5.2.2 Global Azithromycin Tablets Revenue by Application (2024-2029)
5.2.3 Global Azithromycin Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Azithromycin Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Teva Azithromycin Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 CSPC
6.2.1 CSPC Corporation Information
6.2.2 CSPC Description and Business Overview
6.2.3 CSPC Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSPC Azithromycin Tablets Product Portfolio
6.2.5 CSPC Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Azithromycin Tablets Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 wockhardt
6.4.1 wockhardt Corporation Information
6.4.2 wockhardt Description and Business Overview
6.4.3 wockhardt Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 wockhardt Azithromycin Tablets Product Portfolio
6.4.5 wockhardt Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Aurobindo Pharma Azithromycin Tablets Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Pharmaceutical Industries Azithromycin Tablets Product Portfolio
6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.7 Lupin Pharmaceuticals
6.6.1 Lupin Pharmaceuticals Corporation Information
6.6.2 Lupin Pharmaceuticals Description and Business Overview
6.6.3 Lupin Pharmaceuticals Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lupin Pharmaceuticals Azithromycin Tablets Product Portfolio
6.7.5 Lupin Pharmaceuticals Recent Developments/Updates
6.8 Lannett Company
6.8.1 Lannett Company Corporation Information
6.8.2 Lannett Company Description and Business Overview
6.8.3 Lannett Company Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Lannett Company Azithromycin Tablets Product Portfolio
6.8.5 Lannett Company Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Apotex Azithromycin Tablets Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Azithromycin Tablets Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 Sinopharm
6.11.1 Sinopharm Corporation Information
6.11.2 Sinopharm Azithromycin Tablets Description and Business Overview
6.11.3 Sinopharm Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sinopharm Azithromycin Tablets Product Portfolio
6.11.5 Sinopharm Recent Developments/Updates
6.12 Yiling Pharmaceutical
6.12.1 Yiling Pharmaceutical Corporation Information
6.12.2 Yiling Pharmaceutical Azithromycin Tablets Description and Business Overview
6.12.3 Yiling Pharmaceutical Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Yiling Pharmaceutical Azithromycin Tablets Product Portfolio
6.12.5 Yiling Pharmaceutical Recent Developments/Updates
6.13 Jilin Jingxin Pharmaceutical
6.13.1 Jilin Jingxin Pharmaceutical Corporation Information
6.13.2 Jilin Jingxin Pharmaceutical Azithromycin Tablets Description and Business Overview
6.13.3 Jilin Jingxin Pharmaceutical Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jilin Jingxin Pharmaceutical Azithromycin Tablets Product Portfolio
6.13.5 Jilin Jingxin Pharmaceutical Recent Developments/Updates
6.14 Yatal Pharma
6.14.1 Yatal Pharma Corporation Information
6.14.2 Yatal Pharma Azithromycin Tablets Description and Business Overview
6.14.3 Yatal Pharma Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yatal Pharma Azithromycin Tablets Product Portfolio
6.14.5 Yatal Pharma Recent Developments/Updates
6.15 Hapharm Group
6.15.1 Hapharm Group Corporation Information
6.15.2 Hapharm Group Azithromycin Tablets Description and Business Overview
6.15.3 Hapharm Group Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Hapharm Group Azithromycin Tablets Product Portfolio
6.15.5 Hapharm Group Recent Developments/Updates
6.16 Kelun
6.16.1 Kelun Corporation Information
6.16.2 Kelun Azithromycin Tablets Description and Business Overview
6.16.3 Kelun Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Kelun Azithromycin Tablets Product Portfolio
6.16.5 Kelun Recent Developments/Updates
6.17 Furen Medicines
6.17.1 Furen Medicines Corporation Information
6.17.2 Furen Medicines Azithromycin Tablets Description and Business Overview
6.17.3 Furen Medicines Azithromycin Tablets Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Furen Medicines Azithromycin Tablets Product Portfolio
6.17.5 Furen Medicines Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azithromycin Tablets Industry Chain Analysis
7.2 Azithromycin Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azithromycin Tablets Production Mode & Process
7.4 Azithromycin Tablets Sales and Marketing
7.4.1 Azithromycin Tablets Sales Channels
7.4.2 Azithromycin Tablets Distributors
7.5 Azithromycin Tablets Customers
8 Azithromycin Tablets Market Dynamics
8.1 Azithromycin Tablets Industry Trends
8.2 Azithromycin Tablets Market Drivers
8.3 Azithromycin Tablets Market Challenges
8.4 Azithromycin Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research